Control group:lifestyle guidance

4 trials

Sponsors

Huadong Hospital Affiliated to Fudan University, The Second Affiliated Hospital, Zhejiang University School of Medicine, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Shanghai Public Health Clinical Center

Conditions

Helicobacter pylori and Nonalcoholic Fatty Liver DiseaseMetabolic dysfunction associated fatty liver disease, MAFLDmetabolic dysfunction-associated fatty liver diseasmetabolic dysfunction-associated steatotic liver disease

Early Phase 1

Hao Qin Xiao Zhi Fang in the treatment of metabolic dysfunction-associated steatotic liver disease: A randomized controlled study

Active, not recruitingChiCTR2400086661

Xiyuan Hospital of China Academy of Chinese Medical Sciencesmetabolic dysfunction-associated steatotic liver disease

Start: 2024-07-17Updated: 2024-07-15

Phase 3

Efficacy and safety of caffeic acid in improvingmetabolic dysfunction associatedfatty liver disease

RecruitingChiCTR2100052729

Huadong Hospital Affiliated to Fudan UniversityMetabolic dysfunction associated fatty liver disease, MAFLD

Start: 2022-01-01Updated: 2022-08-08

Unknown Phase

Efficacy of Helicobacter pylori eradication therapy in non-alcoholic fatty liver disease: a randomized controlled trial

Active, not recruitingChiCTR2200061243

The Second Affiliated Hospital, Zhejiang University School of MedicineHelicobacter pylori and Nonalcoholic Fatty Liver Disease

Start: 2019-01-01Updated: 2023-03-26

Effects of Eurotium cristatum–Fermented Tea on Hepatic Fat Content in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease

Active, not recruitingChiCTR2600125440

Shanghai Public Health Clinical Centermetabolic dysfunction-associated fatty liver diseas

Start: 2026-05-27Updated: 2026-06-01